{
  "id": 20314274,
  "title": "A possible new approach for treating autism and conditions caused by a single faulty gene copy",
  "url": "https://urgent.news/2026/11/16/a-possible-new-approach-for-treating-autism-and-conditions-caused-by",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-16T19:00:15.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-approach-autism-conditions-faulty-gene.html"
  },
  "original_language": "en",
  "account": "Researchers at UCLA Health have demonstrated in lab-grown human brain cells that increasing the activity of a healthy gene copy can counteract the effects of a mutation associated with autism, as reported in a study published in Nature Neuroscience. This discovery suggests a novel approach for treating autism and related neurodevelopmental disorders, although the findings are still preliminary. Autism is a highly heritable condition, with about 15% of its genetic risk attributed to new mutations that arise in children rather than being inherited from parents. Many of these mutations impair one of the two copies of a gene, causing neurodevelopmental issues due to insufficient production of the gene's product by a single copy. While existing autism treatments primarily target symptoms arising from these genetic mutations, they do not address the underlying biology. The UCLA research team, led by Dr. Daniel Geschwind, investigated two genes frequently linked to autism, CHD8 and SCN2A. CHD8 regulates other genes involved in brain development, and SCN2A is crucial for neurons to generate electrical signals. Rather than replacing or editing the defective gene, the researchers employed a modified CRISPR technique to adjust the activity of the remaining healthy gene copy. The goal was to modulate gene expression in a manner consistent with normal brain development and to prevent excessive gene activity. Dr. Geschwind, a distinguished professor of human genetics, neurology, and psychiatry at UCLA, explained that the results indicate the potential to enhance the expression of the remaining functional gene copy in human cell models, thereby moving cells closer to typical development. The study utilized human stem cell-derived models, including cultures of excitatory neurons and cortical organoids, which replicate early brain development and key features of neurodevelopmental disorders. Key to the approach was its specificity: it only affected cell lines harboring the mutation, leaving healthy cells unaffected. This selectivity is crucial for any future therapeutic application. However, the team emphasized that their findings represent a proof of concept rather than an immediate clinical solution, as the extent of gene expression normalization varied among cell lines and further work is needed on delivery methods and timing before considering a therapeutic application. The researchers highlighted that this strategy, which relies on a functional gene copy, could potentially benefit other neurodevelopmental conditions caused by a single faulty gene copy.",
  "summary": "Researchers at UCLA Health have shown in lab-grown human brain cells that boosting the activity of a healthy gene copy can offset the effects of a mutation linked to autism. The findings, published in Nature Neuroscience, suggest a new direction for treating autism and related neurodevelopmental conditions, though the work is still at an early stage.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}